Saturn V Capital Management as of March 31, 2026
Portfolio Holdings for Saturn V Capital Management
Saturn V Capital Management holds 21 positions in its portfolio as reported in the March 2026 quarterly 13F filing
| Company (Ticker) | Portfolio Weight | Valued At | Change in Shares | Share Count | Share Price |
|---|---|---|---|---|---|
| Alumis (ALMS) | 12.8 | $71M | 3.2M | 22.03 | |
| Amylyx Pharmaceuticals (AMLX) | 10.9 | $61M | 4.3M | 13.90 | |
| Abivax Sa Sponsored Ads (ABVX) | 10.9 | $60M | 543k | 111.35 | |
| Vaxcyte (PCVX) | 8.7 | $48M | 825k | 58.11 | |
| Pharvaris N V (PHVS) | 6.1 | $34M | 1.2M | 28.25 | |
| Immix Biopharma (IMMX) | 6.1 | $34M | 3.7M | 9.11 | |
| Celcuity (CELC) | 5.8 | $32M | 282k | 114.14 | |
| Jazz Pharmaceuticals Shs Usd (JAZZ) | 5.6 | $31M | 163k | 189.05 | |
| Disc Medicine (IRON) | 5.2 | $29M | 450k | 63.94 | |
| X4 Pharmaceuticals Com New (XFOR) | 4.8 | $27M | 6.5M | 4.13 | |
| Cogent Biosciences (COGT) | 4.4 | $24M | 627k | 38.49 | |
| Monopar Therapeutics Com New (MNPR) | 3.4 | $19M | 346k | 54.79 | |
| Dyne Therapeutics (DYN) | 3.2 | $18M | 967k | 18.13 | |
| Adagio Therapeutics (IVVD) | 2.6 | $14M | 11M | 1.30 | |
| Candel Therapeutics (CADL) | 2.6 | $14M | 2.9M | 4.90 | |
| Oculis Holding Ordinary Shares (OCS) | 2.5 | $14M | 517k | 26.59 | |
| Ovid Therapeutics (OVID) | 1.7 | $9.2M | 4.2M | 2.22 | |
| Inhibikase Therapeutics Com New (IKT) | 1.2 | $6.5M | 3.9M | 1.68 | |
| Zura Bio Class A Ord Shs (ZURA) | 0.8 | $4.4M | 740k | 5.95 | |
| Alto Neuroscience Com Shs (ANRO) | 0.4 | $2.0M | 89k | 22.48 | |
| Satellos Bioscience (MSLE) | 0.4 | $2.0M | 350k | 5.63 |
